Supply chain efficiency in the conduct of clinical studies is a critical
factor determining part of the overall cost. When appropriate,
unblinded clinical study supply optimisation can save money, time
and resources, and decrease risk, by preventing costly delays due to
supply shortages. In this piece, Gerald L. Klein, MD and Maxwell O.
Clarke of MedSurgPI, LLC analyse how the expansion of available
resources towards the pharmacy network has helped provide more
efficient clinical study supply management.